Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Succinylcholine | The therapeutic efficacy of Succinylcholine can be increased when used in combination with Isepamicin. |
| Metocurine iodide | The therapeutic efficacy of Metocurine iodide can be increased when used in combination with Isepamicin. |
| Gallamine triethiodide | The therapeutic efficacy of Gallamine triethiodide can be increased when used in combination with Isepamicin. |
| Cisatracurium | Isepamicin may increase the neuromuscular blocking activities of Cisatracurium. |
| Rocuronium | The therapeutic efficacy of Rocuronium can be increased when used in combination with Isepamicin. |
| Atracurium besylate | The therapeutic efficacy of Atracurium besylate can be increased when used in combination with Isepamicin. |
| Doxacurium | The therapeutic efficacy of Doxacurium can be increased when used in combination with Isepamicin. |
| Mivacurium | The therapeutic efficacy of Mivacurium can be increased when used in combination with Isepamicin. |
| Decamethonium | The therapeutic efficacy of Decamethonium can be increased when used in combination with Isepamicin. |
| Metocurine | The therapeutic efficacy of Metocurine can be increased when used in combination with Isepamicin. |
| Pancuronium | The therapeutic efficacy of Pancuronium can be increased when used in combination with Isepamicin. |
| Pipecuronium | The therapeutic efficacy of Pipecuronium can be increased when used in combination with Isepamicin. |
| Vecuronium | The therapeutic efficacy of Vecuronium can be increased when used in combination with Isepamicin. |
| Rapacuronium | The therapeutic efficacy of Rapacuronium can be increased when used in combination with Isepamicin. |
| Pyrantel | The therapeutic efficacy of Pyrantel can be increased when used in combination with Isepamicin. |
| Neosaxitoxin | The therapeutic efficacy of Neosaxitoxin can be increased when used in combination with Isepamicin. |
| Atracurium | The therapeutic efficacy of Atracurium can be increased when used in combination with Isepamicin. |
| Gallamine | The therapeutic efficacy of Gallamine can be increased when used in combination with Isepamicin. |
| Alcuronium | The therapeutic efficacy of Alcuronium can be increased when used in combination with Isepamicin. |
| Tubocurarine | The therapeutic efficacy of Tubocurarine can be increased when used in combination with Isepamicin. |
| Carboplatin | The risk or severity of ototoxicity and nephrotoxicity can be increased when Isepamicin is combined with Carboplatin. |
| Foscarnet | The risk or severity of nephrotoxicity can be increased when Isepamicin is combined with Foscarnet. |
| Mannitol | The risk or severity of nephrotoxicity can be increased when Mannitol is combined with Isepamicin. |
| Tenofovir disoproxil | Isepamicin may increase the nephrotoxic activities of Tenofovir disoproxil. |
| Tenofovir alafenamide | Isepamicin may increase the nephrotoxic activities of Tenofovir alafenamide. |
| Tenofovir | Isepamicin may increase the nephrotoxic activities of Tenofovir. |
| Picosulfuric acid | The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Isepamicin. |
| Zoledronic acid | The risk or severity of nephrotoxicity and hypocalcemia can be increased when Isepamicin is combined with Zoledronic acid. |
| Alendronic acid | The risk or severity of nephrotoxicity and hypocalcemia can be increased when Isepamicin is combined with Alendronic acid. |
| Ibandronate | The risk or severity of nephrotoxicity and hypocalcemia can be increased when Isepamicin is combined with Ibandronate. |
| Clodronic acid | The risk or severity of nephrotoxicity and hypocalcemia can be increased when Isepamicin is combined with Clodronic acid. |
| Risedronic acid | The risk or severity of nephrotoxicity and hypocalcemia can be increased when Isepamicin is combined with Risedronic acid. |
| Etidronic acid | The risk or severity of nephrotoxicity and hypocalcemia can be increased when Isepamicin is combined with Etidronic acid. |
| Incadronic acid | The risk or severity of nephrotoxicity and hypocalcemia can be increased when Isepamicin is combined with Incadronic acid. |
| Taxifolin | The risk or severity of nephrotoxicity can be increased when Taxifolin is combined with Isepamicin. |
| Licofelone | The risk or severity of nephrotoxicity can be increased when Licofelone is combined with Isepamicin. |
| Polmacoxib | The risk or severity of nephrotoxicity can be increased when Polmacoxib is combined with Isepamicin. |
| Ebselen | The risk or severity of nephrotoxicity can be increased when Ebselen is combined with Isepamicin. |
| Flurbiprofen axetil | The risk or severity of nephrotoxicity can be increased when Flurbiprofen axetil is combined with Isepamicin. |
| Acetyldigitoxin | The risk or severity of adverse effects can be increased when Isepamicin is combined with Acetyldigitoxin. |
| Deslanoside | The risk or severity of adverse effects can be increased when Isepamicin is combined with Deslanoside. |
| Ouabain | The risk or severity of adverse effects can be increased when Isepamicin is combined with Ouabain. |
| Digitoxin | The risk or severity of adverse effects can be increased when Isepamicin is combined with Digitoxin. |
| Oleandrin | The risk or severity of adverse effects can be increased when Isepamicin is combined with Oleandrin. |
| Cymarin | The risk or severity of adverse effects can be increased when Isepamicin is combined with Cymarin. |
| Proscillaridin | The risk or severity of adverse effects can be increased when Isepamicin is combined with Proscillaridin. |
| Metildigoxin | The risk or severity of adverse effects can be increased when Isepamicin is combined with Metildigoxin. |
| Lanatoside C | The risk or severity of adverse effects can be increased when Isepamicin is combined with Lanatoside C. |
| Gitoformate | The risk or severity of adverse effects can be increased when Isepamicin is combined with Gitoformate. |
| Acetyldigoxin | The risk or severity of adverse effects can be increased when Isepamicin is combined with Acetyldigoxin. |
| Peruvoside | The risk or severity of adverse effects can be increased when Isepamicin is combined with Peruvoside. |
| Torasemide | The serum concentration of Isepamicin can be increased when it is combined with Torasemide. |
| Bumetanide | The serum concentration of Isepamicin can be increased when it is combined with Bumetanide. |
| Etacrynic acid | The serum concentration of Isepamicin can be increased when it is combined with Etacrynic acid. |
| Piretanide | The serum concentration of Isepamicin can be increased when it is combined with Piretanide. |
| Azosemide | The serum concentration of Isepamicin can be increased when it is combined with Azosemide. |
| Tripamide | The serum concentration of Isepamicin can be increased when it is combined with Tripamide. |
| Flucloxacillin | The serum concentration of Isepamicin can be decreased when it is combined with Flucloxacillin. |
| Phenoxymethylpenicillin | The serum concentration of Isepamicin can be decreased when it is combined with Phenoxymethylpenicillin. |
| Dicloxacillin | The serum concentration of Isepamicin can be decreased when it is combined with Dicloxacillin. |
| Carbenicillin | The serum concentration of Isepamicin can be decreased when it is combined with Carbenicillin. |
| Nafcillin | The serum concentration of Isepamicin can be decreased when it is combined with Nafcillin. |
| Hetacillin | The serum concentration of Isepamicin can be decreased when it is combined with Hetacillin. |
| Benzylpenicilloyl polylysine | The serum concentration of Isepamicin can be decreased when it is combined with Benzylpenicilloyl polylysine. |
| Mezlocillin | The serum concentration of Isepamicin can be decreased when it is combined with Mezlocillin. |
| Cyclacillin | The serum concentration of Isepamicin can be decreased when it is combined with Cyclacillin. |
| Benzylpenicillin | The serum concentration of Isepamicin can be decreased when it is combined with Benzylpenicillin. |
| Azlocillin | The serum concentration of Isepamicin can be decreased when it is combined with Azlocillin. |
| Cloxacillin | The serum concentration of Isepamicin can be decreased when it is combined with Cloxacillin. |
| Amdinocillin | The serum concentration of Isepamicin can be decreased when it is combined with Amdinocillin. |
| Bacampicillin | The serum concentration of Isepamicin can be decreased when it is combined with Bacampicillin. |
| Meticillin | The serum concentration of Isepamicin can be decreased when it is combined with Meticillin. |
| Pivampicillin | The serum concentration of Isepamicin can be decreased when it is combined with Pivampicillin. |
| Pivmecillinam | The serum concentration of Isepamicin can be decreased when it is combined with Pivmecillinam. |
| Ticarcillin | The serum concentration of Isepamicin can be decreased when it is combined with Ticarcillin. |
| Azidocillin | The serum concentration of Isepamicin can be decreased when it is combined with Azidocillin. |
| Carindacillin | The serum concentration of Isepamicin can be decreased when it is combined with Carindacillin. |
| Sultamicillin | The serum concentration of Isepamicin can be decreased when it is combined with Sultamicillin. |
| Temocillin | The serum concentration of Isepamicin can be decreased when it is combined with Temocillin. |
| Epicillin | The serum concentration of Isepamicin can be decreased when it is combined with Epicillin. |
| Pheneticillin | The serum concentration of Isepamicin can be decreased when it is combined with Pheneticillin. |
| Carfecillin | The serum concentration of Isepamicin can be decreased when it is combined with Carfecillin. |
| Propicillin | The serum concentration of Isepamicin can be decreased when it is combined with Propicillin. |
| Clometocillin | The serum concentration of Isepamicin can be decreased when it is combined with Clometocillin. |
| Sulbenicillin | The serum concentration of Isepamicin can be decreased when it is combined with Sulbenicillin. |
| Penamecillin | The serum concentration of Isepamicin can be decreased when it is combined with Penamecillin. |
| Talampicillin | The serum concentration of Isepamicin can be decreased when it is combined with Talampicillin. |
| Aspoxicillin | The serum concentration of Isepamicin can be decreased when it is combined with Aspoxicillin. |
| Metampicillin | The serum concentration of Isepamicin can be decreased when it is combined with Metampicillin. |
| BCG vaccine | The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Isepamicin. |
| Typhoid vaccine | The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Isepamicin. |
| Lymecycline | The risk or severity of neuromuscular blockade can be increased when Lymecycline is combined with Isepamicin. |
| Clomocycline | The risk or severity of neuromuscular blockade can be increased when Clomocycline is combined with Isepamicin. |
| Quinine | The risk or severity of neuromuscular blockade can be increased when Quinine is combined with Isepamicin. |
| Tigecycline | The risk or severity of neuromuscular blockade can be increased when Tigecycline is combined with Isepamicin. |
| Oxytetracycline | The risk or severity of neuromuscular blockade can be increased when Oxytetracycline is combined with Isepamicin. |
| Demeclocycline | The risk or severity of neuromuscular blockade can be increased when Demeclocycline is combined with Isepamicin. |
| Magnesium sulfate | The risk or severity of neuromuscular blockade can be increased when Magnesium sulfate is combined with Isepamicin. |
| Metacycline | The risk or severity of neuromuscular blockade can be increased when Metacycline is combined with Isepamicin. |
| Minocycline | The risk or severity of neuromuscular blockade can be increased when Minocycline is combined with Isepamicin. |